Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Mol Biosyst. 2010 Jun 28;6(8):1389–1402. doi: 10.1039/c003917a

Fig. 1.

Fig. 1

(a) Structures of disclosed Akt inhibitors in clinical development. (b) Analog sensitive design strategy. Crystal structure of Akt2 with A443654 shows the native gatekeeper methionine and its proximity to the 7 position of indazole ring. Structures of PP1 derivatives commonly used to inhibit analog sensitive kinases.